Back
40
Day Range
$265.47
$269.97
52-Week Range
$209.38
$293.72
Volume
474,904
50D / 200D Avg
$272.78
/
$267.35
Prev Close
$266.12
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 25.2 | 0.2 |
| P/B | 2.6 | 3.0 |
| ROE % | 10.5 | 3.6 |
| Net Margin % | 6.3 | 3.8 |
| Rev Growth 5Y % | 1.5 | 9.9 |
| D/E | 0.8 | 0.2 |
Analyst Price Target
Hold
$315.38
+18.6%
Low: $290.00
High: $342.00
Forward P/E
14.89
Forward EPS
$17.86
EPS Growth (est.)
+0.0%
Est. Revenue
14.67B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$23.80
$23.42 – $24.14
|
15.22B | 1 |
| FY2029 |
$23.23
$22.85 – $23.56
|
17.34B | 1 |
| FY2028 |
$21.07
$19.66 – $23.85
|
16.18B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-17 | $3.95 | $4.07 | +3.0% |
| 2025-10-28 | $4.13 | $4.18 | +1.2% |
| 2025-07-24 | $4.17 | $4.35 | +4.3% |
| 2025-04-29 | $3.74 | $3.84 | +2.7% |
| 2025-02-06 | $3.39 | $3.45 | +1.8% |
| 2024-10-24 | $3.47 | $3.50 | +0.9% |
| 2024-08-01 | $3.78 | $3.94 | +4.2% |
| 2024-04-25 | $3.48 | $3.68 | +5.7% |
Dividend History
4 yr streakYield
0.01%
Payout Ratio
0.27%
Growth (3Y)
10.06%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 27, 2026 | Mar 12, 2026 | $0.72 | 1.00% |
| Nov 26, 2025 | Dec 11, 2025 | $0.72 | 1.07% |
| Aug 28, 2025 | Sep 11, 2025 | $0.72 | 1.05% |
| May 29, 2025 | Jun 11, 2025 | $0.72 | 1.17% |
| Feb 27, 2025 | Mar 12, 2025 | $0.72 | 1.16% |
| Nov 26, 2024 | Dec 13, 2024 | $0.72 | 1.21% |
| Aug 29, 2024 | Sep 13, 2024 | $0.72 | 1.25% |
| May 24, 2024 | Jun 12, 2024 | $0.72 | 1.44% |
| Feb 26, 2024 | Mar 13, 2024 | $0.72 | 1.29% |
| Nov 07, 2023 | Dec 12, 2023 | $0.72 | 1.29% |
| Aug 07, 2023 | Sep 08, 2023 | $0.72 | 1.20% |
| May 17, 2023 | Jun 08, 2023 | $0.72 | 1.33% |
| Feb 22, 2023 | Mar 13, 2023 | $0.72 | 1.19% |
| Nov 16, 2022 | Dec 09, 2022 | $0.72 | 0.89% |
| Aug 17, 2022 | Sep 09, 2022 | $0.72 | 0.57% |
| May 18, 2022 | Jun 09, 2022 | $0.72 | 0.30% |
| Mar 29, 1994 | Apr 26, 1994 | $0.08 | 2.37% |
| Dec 29, 1993 | Jan 25, 1994 | $0.08 | 2.31% |
| Sep 29, 1993 | Oct 26, 1993 | $0.08 | 2.06% |
| Jun 29, 1993 | Jul 27, 1993 | $0.08 | 1.78% |
Key Takeaways
Revenue grew 1.52% annually over 5 years — modest growth
Earnings grew 17.49% over the past year
ROE of 10.51% — decent returns on equity
Generating 1.21B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.73%
Cash machine — converts 137.59% of earnings into free cash flow
Growth
Revenue Growth (5Y)
1.52%
Revenue (1Y)7.25%
Earnings (1Y)17.49%
FCF Growth (3Y)17.46%
Quality
Return on Equity
10.51%
ROIC7.19%
Net Margin6.28%
Op. Margin10.87%
Safety
Debt / Equity
0.84
Current Ratio1.42
Interest Coverage6.77
Valuation
P/E Ratio
25.16
Forward P/E14.89
P/B Ratio2.56
EV/EBITDA18.95
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.25% | Revenue Growth (3Y) | 7.11% |
| Earnings Growth (1Y) | 17.49% | Earnings Growth (3Y) | 44.81% |
| Revenue Growth (5Y) | 1.52% | Earnings Growth (5Y) | -22.08% |
| Profitability | |||
| Revenue (TTM) | 13.95B | Net Income (TTM) | 876.50M |
| ROE | 10.51% | ROA | 4.77% |
| Gross Margin | 26.75% | Operating Margin | 10.87% |
| Net Margin | 6.28% | Free Cash Flow (TTM) | 1.21B |
| ROIC | 7.19% | FCF Growth (3Y) | 17.46% |
| Safety | |||
| Debt / Equity | 0.84 | Current Ratio | 1.42 |
| Interest Coverage | 6.77 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.27% |
| Dividend Growth (3Y) | 10.06% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 4 yrs | ||
| Valuation | |||
| P/E Ratio | 25.16 | Forward P/E | 14.89 |
| P/B Ratio | 2.56 | P/S Ratio | 1.58 |
| PEG Ratio | 1.28 | Forward PEG | N/A |
| EV/EBITDA | 18.95 | Fwd EV/EBITDA | 11.67 |
| Forward P/S | 1.50 | Fwd Earnings Yield | 6.72% |
| FCF Yield | 5.47% | ||
| Market Cap | 22.05B | Enterprise Value | 28.72B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13.95B | 13.01B | 12.16B | 11.86B | 13.14B |
| Net Income | 876.50M | 746.00M | 418.00M | 1.28B | 2.38B |
| EPS (Diluted) | 10.46 | 8.84 | 4.77 | 13.96 | 24.38 |
| Gross Profit | 3.73B | 3.62B | 3.36B | 3.71B | 4.99B |
| Operating Income | 1.52B | 1.09B | 725.60M | 1.44B | 3.05B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 18.39B | 18.38B | 16.73B | 20.16B | 20.39B |
| Total Liabilities | 9.76B | 10.31B | 8.83B | 10.04B | 10.09B |
| Shareholders' Equity | 8.62B | 8.05B | 7.88B | 10.10B | 10.27B |
| Total Debt | 7.20B | 7.27B | 5.95B | 6.25B | 6.34B |
| Cash & Equivalents | 532.30M | 1.52B | 536.80M | 320.60M | 1.47B |
| Current Assets | 4.02B | 4.81B | 3.77B | 4.63B | 5.33B |
| Current Liabilities | 2.82B | 3.33B | 3.23B | 3.08B | 2.78B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#624 of 1049
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026